C. Capeans et al., C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy, RETINA, 18(6), 1998, pp. 546-550
Citations number
26
Categorie Soggetti
Optalmology
Journal title
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Purpose: To investigate the presence of three C-C chemokines (monocyte chem
otactic protein-1 [MCP-1], macrophage inflammatory protein-1 alpha [MIP-1 a
lpha], and MIP-1 beta) in vitreous samples from eyes with proliferative vit
reoretinopathy (PVR), proliferative diabetic retinopathy (PDR), or retinal
detachment (RD).
Subjects and Methods: Vitreous samples were obtained and assayed by solid p
hase enzyme-linked immunosorbent assay for the chemokines MCP-1, MIP-1 alph
a, and MIP-1 beta in a prospective study of 43 consecutive patients. Eighte
en samples from cadaveric control eyes were also assayed.
Results: Monocyte chemotactic protein-1 was detected in all samples. The vi
treous of eyes with vitreoretinal disorders showed significantly higher lev
els than the vitreous of cadaveric control eyes (P less than or equal to 0.
05). Median level (5th-95th percentile) in the PVR cases (n = 20) was 890.1
8 pg/mL (286.04-1806.20); in RD (n = 8), 296.69 pg/mL (171.44-1310.02); and
in PDR (n = 15), 434.60 pg/mL (124.56-1092.94). in the cadaveric control e
yes (n = 18), median level was 83.97 pg/mL (26.09-208.38). Macrophage infla
mmatory protein-1 alpha and MIP-1 beta were not detected in any samples.
Conclusion: Monocyte chemotactic protein-1 might be involved in the recruit
ment of macrophages and monocytes into the vitreous of eyes with proliferat
ive vitreoretinal disorders.